Bringing the fundamentals into focus…
Back to NeoGenomics, Inc.
How NeoGenomics, Inc. stacks up
NEO · against 357 other Healthcare companies of similar size
Growth
60/ 100
Above the middle of the pack.
Ranked #165 of 358 · scores higher than 54% of peers
Bars: peers in each 10-point band of the growth score47 peers with a growth score of 60–69, including NEO · Click a bar to see the companies
Why growth scores 60?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over the last year: stronger than 64% of peers. Revenue growth: 11.2% vs peer median 6.1%
- faster revenue growth over three years: stronger than 67% of peers. 3-year revenue growth: 11.6% vs peer median 5.8%
Metric by metric
Position: dot = NEO, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | NEO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 358 reported | 11.2% | 6.9% | 59% | 33% | |
| Earnings per share growthHigher is better · 205 reported | Not reported | 10.0% | — | — | 33% |
| 3-year revenue growthHigher is better · 350 reported | 11.6% | 8.4% | 60% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around NEO| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 2.1B USD | 99 | 96 | |
| 159 | 4.3B USD | 61 | 54 | |
| 159 | 3.2B USD | 61 | 65 | |
| 159 | 1.6B USD | 61 | 51 | |
| 159 | 151.7B INR (≈$1.8B) | 61 | 61 | |
| 165 | 2.2B USD | 60 | 36 | |
| 165 | 2.2B USD | 60 | 61 | |
| 165 | 303.5B INR (≈$3.6B) | 60 | 47 | |
| 168 | 427.8B JPY (≈$2.9B) | 59 | 52 | |
| 168 | 1.2B CHF (≈$1.4B) | 59 | 34 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score